IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,778,459 | -41.4% | 252,622 | -49.2% | 0.01% | -36.8% |
| Q1 2023 | $3,036,542 | -23.1% | 496,979 | -19.5% | 0.02% | -17.4% |
| Q4 2022 | $3,946,598 | -9.9% | 617,621 | +35.2% | 0.02% | -8.0% |
| Q3 2022 | $4,378,000 | +46.8% | 456,947 | +69.1% | 0.02% | +38.9% |
| Q2 2022 | $2,983,000 | -16.9% | 270,238 | +25.3% | 0.02% | -40.0% |
| Q1 2022 | $3,590,000 | +0.1% | 215,645 | +14.8% | 0.03% | -11.8% |
| Q4 2021 | $3,585,000 | -43.1% | 187,785 | -26.4% | 0.03% | -57.0% |
| Q3 2021 | $6,296,000 | +23218.5% | 255,299 | +24400.9% | 0.08% | – |
| Q2 2021 | $27,000 | -99.1% | 1,042 | -98.9% | 0.00% | -100.0% |
| Q1 2021 | $3,123,000 | +144.4% | 98,642 | +258.3% | 0.04% | +122.2% |
| Q4 2020 | $1,278,000 | +34.5% | 27,534 | -4.6% | 0.02% | +28.6% |
| Q3 2020 | $950,000 | -88.0% | 28,851 | -90.0% | 0.01% | -89.8% |
| Q2 2020 | $7,903,000 | +1219.4% | 287,903 | +1231.2% | 0.14% | +1145.5% |
| Q4 2019 | $599,000 | -39.1% | 21,628 | -60.0% | 0.01% | -45.0% |
| Q3 2019 | $984,000 | +720.0% | 54,067 | +1000.3% | 0.02% | +900.0% |
| Q2 2019 | $120,000 | -43.1% | 4,914 | -77.8% | 0.00% | -71.4% |
| Q1 2019 | $211,000 | +66.1% | 22,150 | +54.0% | 0.01% | +16.7% |
| Q4 2018 | $127,000 | -47.3% | 14,385 | +0.7% | 0.01% | -57.1% |
| Q1 2018 | $241,000 | – | 14,284 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |